Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
71.29
-1.63 (-2.24%)
At close: Dec 4, 2025
57.20%
Market Cap 30.86B
Revenue (ttm) 10.59B
Net Income (ttm) 227.00M
Shares Out n/a
EPS (ttm) 0.52
PE Ratio 135.95
Forward PE 19.63
Dividend 0.73 (1.06%)
Ex-Dividend Date Apr 17, 2025
Volume 321
Average Volume 274
Open 70.80
Previous Close 72.92
Day's Range 70.80 - 71.29
52-Week Range 36.68 - 72.92
Beta 0.27
RSI 73.78
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.